Can quantified pathologic response assessed as residual tumor burden be a promising staging system for patients with rectal cancer treated with chemoradiation followed by surgery?
- PMID: 24474633
- DOI: 10.1002/cncr.28560
Can quantified pathologic response assessed as residual tumor burden be a promising staging system for patients with rectal cancer treated with chemoradiation followed by surgery?
Comment in
-
Reply to Can quantified pathologic response assessed as residual tumor burden be a promising staging system for patients with rectal cancer treated with chemoradiation followed by surgery?Cancer. 2014 Apr 15;120(8):1282. doi: 10.1002/cncr.28559. Epub 2014 Jan 28. Cancer. 2014. PMID: 24474599 No abstract available.
Comment on
-
Quantified pathologic response assessed as residual tumor burden is a predictor of recurrence-free survival in patients with rectal cancer who undergo resection after neoadjuvant chemoradiotherapy.Cancer. 2013 Dec 15;119(24):4231-41. doi: 10.1002/cncr.28331. Epub 2013 Oct 1. Cancer. 2013. PMID: 24089344 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
